Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

PUBLISHED: November 2, 2023

PAGES: 150 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global mosquito borne disease market size is expected to reach US$ 5.10 Bn by 2030, from US$ 3.11 Bn in 2023, exhibiting a CAGR of 7.3% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.11 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.30%	2030 Value Projection:	US$ 5.10 Bn

Figure 1. Global Mosquito Borne Disease Market Share (%), By Region, 2023

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Global Mosquito Borne Disease Market Detailed Segmentation:

By Disease Type
- Malaria
- Dengue
- Yellow Fever
- West Nile Virus
- Chikungunya
- Zika Virus
- Others
By Treatment Type
- Medication
- Vaccination
- Vector Control Methods
- Immunotherapy
- Supportive Care
- Others
By End User
- Hospitals
- Clinics
- Diagnostic Centers
- Research Institutes
- Government Organizations
- NGOs
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Key Players:
- GlaxoSmithKline plc
- Sanofi S.A.
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- Eisai Co., Ltd
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Valeant Pharmaceuticals International, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Abbott
- Hoffmann-La Roche Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Serum Institute of India Pvt. Ltd.
- CSL Limited
- Teva Pharmaceutical Industries Ltd

Product Code: CMI6241

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Mosquito Borne Disease, By Disease Type
- Market Mosquito Borne Disease, By Treatment Type
- Market Mosquito Borne Disease, By End User
- Market Mosquito Borne Disease, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Malaria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
West Nile Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Vector Control Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bin)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
NGOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson
Eisai Co., Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca
Valeant Pharmaceuticals International, Inc.
Mitsubishi Tanabe Pharma Corporation
Abbott
Hoffmann-La Roche Ltd
Sun Pharmaceutical Industries Ltd
Lupin Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Serum Institute of India Pvt. Ltd.
CSL Limited
Teva Pharmaceutical Industries Ltd
Analyst Views